Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 1
Submit an article Journal homepage
242
Views
12
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia

Isabelle HerthDepartment of Medicine V, University of Heidelberg, GermanyCorrespondence[email protected]
,
Manfred HenselDepartment of Medicine V, University of Heidelberg, Germany;Private Oncology Practice, Mannheim, Germany
,
Michael RiegerPrivate Oncology Practice, Darmstadt, Germany
,
Kristin HorstmannDepartment of Medicine V, University of Heidelberg, Germany
,
Wolfgang HiddemannDepartment of Medicine III, University Hospital Grosshadern/LMU, Munich, Germany
,
Martin DreylingDepartment of Medicine III, University Hospital Grosshadern/LMU, Munich, Germany
,
Silvia KoniczekPrivate Oncology Practice, Heilbronn, Germany
,
Mathias Witzens-HarigDepartment of Medicine V, University of Heidelberg, Germany
&
Anthony D. HoDepartment of Medicine V, University of Heidelberg, Germany
 show all
Pages 97-102 | Received 21 Feb 2014, Accepted 30 Mar 2014, Published online: 25 Jun 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ilias Pessach, Meletios A. Dimopoulos & Efstathios Kastritis. (2021) Managing complications secondary to Waldenström’s macroglobulinemia. Expert Review of Hematology 14:7, pages 621-632.
Read now

Articles from other publishers (11)

Barbara Kutryb-Zając, Ada Kawecka, Khrystyna Nasadiuk, Alicja Braczko, Klaudia Stawarska, Elisabetta Caiazzo, Patrycja Koszałka & Carla Cicala. (2023) Drugs targeting adenosine signaling pathways: A current view. Biomedicine & Pharmacotherapy 165, pages 115184.
Crossref
Prashant Kapoor, Jonas Paludo & Jithma P. Abeykoon. (2023) Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy. Hematology/Oncology Clinics of North America 37:4, pages 671-687.
Crossref
Hongyu Zhang, Ran Liu, Tingting Lou, Pei Zhao & Suying Wang. (2022) Pentostatin Biosynthesis Pathway Elucidation and Its Application. Fermentation 8:9, pages 459.
Crossref
Morie A. Gertz. (2021) Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management. American Journal of Hematology 96:2, pages 258-269.
Crossref
Morie A. Gertz. (2019) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology 94:2, pages 266-276.
Crossref
Alessandra Tedeschi & Anna Maria Frustaci. (2019) Waldenström's macroglobulinemia front line treatment. HemaSphere 3, pages 62-64.
Crossref
Morie A. Gertz. (2018) Waldenström macroglobulinemia treatment algorithm 2018. Blood Cancer Journal 8:4.
Crossref
Adam J. Olszewski, Chang Chen, Roee Gutman, Steven P. Treon & Jorge J. Castillo. (2017) Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia. British Journal of Haematology 179:1, pages 106-115.
Crossref
Morie A. Gertz. (2017) Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. American Journal of Hematology 92:2, pages 209-217.
Crossref
Dominic A. SolimandoJrJr & J. Aubrey Waddell. (2016) Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen. Hospital Pharmacy 51:11, pages 888-893.
Crossref
Prashant Kapoor, Jonas Paludo & Stephen M. Ansell. (2016) Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection. Current Treatment Options in Oncology 17:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.